These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 17296468)
1. Psychometric evaluation of the medical outcomes study-sleep scale in persons with overactive bladder. Lau DT; Morlock RJ; Hill CD Clin Ther; 2006 Dec; 28(12):2119-32. PubMed ID: 17296468 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire. Piault E; Evans CJ; Espindle D; Kopp Z; Brubaker L; Abrams P Neurourol Urodyn; 2008; 27(3):179-90. PubMed ID: 17565727 [TBL] [Abstract][Full Text] [Related]
3. Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep). Allen RP; Kosinski M; Hill-Zabala CE; Calloway MO Sleep Med; 2009 May; 10(5):531-9. PubMed ID: 18805054 [TBL] [Abstract][Full Text] [Related]
4. Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q). Margolis MK; Fox KM; Cerulli A; Ariely R; Kahler KH; Coyne KS Neurourol Urodyn; 2009; 28(5):416-22. PubMed ID: 19030182 [TBL] [Abstract][Full Text] [Related]
5. The psychometric validation of the OAB family impact measure (OAB-FIM). Coyne KS; Matza LS; Brewster-Jordan J; Thompson C; Bavendam T Neurourol Urodyn; 2010 Mar; 29(3):359-69. PubMed ID: 19274760 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study. Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275 [TBL] [Abstract][Full Text] [Related]
7. Understanding the elements of overactive bladder: questions raised by the EPIC study. Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K; BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602 [TBL] [Abstract][Full Text] [Related]
8. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794 [TBL] [Abstract][Full Text] [Related]
9. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689 [TBL] [Abstract][Full Text] [Related]
10. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China. Wang Y; Xu K; Hu H; Zhang X; Wang X; Na Y; Kang X Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714 [TBL] [Abstract][Full Text] [Related]
11. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes. Garely AD; Lucente V; Vapnek J; Smith N Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526 [TBL] [Abstract][Full Text] [Related]
12. Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder. Colman S; Chapple C; Nitti V; Haag-Molkenteller C; Hastedt C; Massow U Urology; 2008 Oct; 72(4):803-7. PubMed ID: 18722655 [TBL] [Abstract][Full Text] [Related]
13. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine. Coyne KS; Elinoff V; Gordon DA; Deng DY; Brodsky M; Glasser DB; Jumadilova Z; Carlsson M Int J Clin Pract; 2008 Jun; 62(6):925-31. PubMed ID: 18479285 [TBL] [Abstract][Full Text] [Related]
14. The relationship between obstructive sleep apnea, nocturia, and daytime overactive bladder syndrome in women. Lowenstein L; Kenton K; Brubaker L; Pillar G; Undevia N; Mueller ER; FitzGerald MP Am J Obstet Gynecol; 2008 May; 198(5):598.e1-5. PubMed ID: 18455544 [TBL] [Abstract][Full Text] [Related]
15. Health-related consequences of overactive bladder. Wagner TH; Hu TW; Bentkover J; LeBlanc K; Stewart W; Corey R; Zhou Z; Hunt T Am J Manag Care; 2002 Dec; 8(19 Suppl):S598-607. PubMed ID: 12516954 [TBL] [Abstract][Full Text] [Related]
16. Impact of self-perceived bothersomeness on health-related quality of life in women with overactive bladder symptoms. Oh SJ; Ku JH Urol Int; 2007; 78(1):63-9. PubMed ID: 17192735 [TBL] [Abstract][Full Text] [Related]
17. Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia. Cappelleri JC; Bushmakin AG; McDermott AM; Dukes E; Sadosky A; Petrie CD; Martin S Sleep Med; 2009 Aug; 10(7):766-70. PubMed ID: 19185539 [TBL] [Abstract][Full Text] [Related]
18. Symptom severity and patient perceptions in overactive bladder: how are they related? Homma Y; Gotoh M BJU Int; 2009 Oct; 104(7):968-72. PubMed ID: 19338560 [TBL] [Abstract][Full Text] [Related]
19. Impact of overactive bladder on women in the United States: results of a national survey. Dmochowski RR; Newman DK Curr Med Res Opin; 2007 Jan; 23(1):65-76. PubMed ID: 17257467 [TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life and sexual function in women with stress urinary incontinence and overactive bladder. Oh SJ; Ku JH; Choo MS; Yun JM; Kim DY; Park WH Int J Urol; 2008 Jan; 15(1):62-7; discussion 67. PubMed ID: 18184175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]